Astrana Health (NASDAQ:ASTH) Stock Price Down 4.8% – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH) shares fell 4.8% during trading on Wednesday . The company traded as low as $36.32 and last traded at $36.4710. 137,474 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 501,517 shares. The stock had previously closed at $38.29.

Wall Street Analyst Weigh In

A number of research firms recently commented on ASTH. Truist Financial upped their price objective on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a research report on Thursday, May 14th. Weiss Ratings upgraded shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 1st. BTIG Research restated a “buy” rating and set a $50.00 target price on shares of Astrana Health in a report on Tuesday, June 2nd. Needham & Company LLC raised their target price on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Finally, TD Cowen raised their target price on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Stock Down 1.2%

The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of 61.95 and a beta of 1.00. The firm’s fifty day simple moving average is $33.98 and its 200 day simple moving average is $27.19.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. During the same period last year, the company posted $0.42 EPS. The business’s quarterly revenue was up 55.6% on a year-over-year basis. On average, sell-side analysts forecast that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Institutional Trading of Astrana Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Signaturefd LLC raised its holdings in shares of Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after buying an additional 871 shares during the last quarter. Strs Ohio acquired a new position in shares of Astrana Health during the 4th quarter worth about $40,000. Tower Research Capital LLC TRC boosted its stake in shares of Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares during the last quarter. Finally, State of Wyoming acquired a new position in shares of Astrana Health during the 2nd quarter worth about $132,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.